Showing 1 - 16 results of 16 for search 'Torben Frøstrup Hansen', query time: 0.06s
Refine Results
-
1
-
2
-
3
Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab by Torben Frøstrup Hansen, Rikke Fredslund Andersen, Dorte Aalund Olsen, Flemming Brandt Sørensen, Anders Jakobsen
Published 2017-05-01
Article -
4
-
5
Missingness mechanisms and generalizability of patient reported outcome measures in colorectal cancer survivors – assessing the reasonableness of the “missing completely at random”... by Johanne Dam Lyhne, Allan ‘Ben’ Smith, Lars Henrik Jensen, Torben Frøstrup Hansen, Lisbeth Frostholm, Signe Timm
Published 2024-05-01
Article -
6
MicroRNA Expression Profiling to Identify and Validate Reference Genes for the Relative Quantification of microRNA in Rectal Cancer. by Anne Haahr Mellergaard Eriksen, Rikke Fredslund Andersen, Niels Pallisgaard, Flemming Brandt Sørensen, Anders Jakobsen, Torben Frøstrup Hansen
Published 2016-01-01
Article -
7
-
8
Enhancing patient engagement: the influence of an in-consult patient decision aid on shared decision-making for lung tumour radiation – protocol for the randomised trial ‘SDM Lung... by Karina Dahl Steffensen, Signe Timm, Torben Frøstrup Hansen, Thomas Leth Fink, Charlotte Kristiansen, Torben Schjødt Hansen, Rune Slot Thing
Published 2025-01-01
Article -
9
Natural killer cell activity as a biomarker for the diagnosis of lung cancer in high-risk patients by Morten Borg, Sara Witting Christensen Wen, Torben Frøstrup Hansen, Anders Jakobsen, Rikke Fredslund Andersen, Ole Hilberg, Ulla Møller Weinreich, Line Nederby
Published 2022-06-01
Article -
10
Identification of patients’ smoking status using an explainable AI approach: a Danish electronic health records case study by Ali Ebrahimi, Margrethe Bang Høstgaard Henriksen, Claus Lohman Brasen, Ole Hilberg, Torben Frøstrup Hansen, Lars Henrik Jensen, Abdolrahman Peimankar, Uffe Kock Wiil
Published 2024-05-01
Article -
11
Soluble programmed death ligand 1 as prognostic biomarker in non-small cell lung cancer patients receiving nivolumab, pembrolizumab or atezolizumab therapy by Sinne Søberg Brun, Torben Frøstrup Hansen, Sara Witting Christensen Wen, Christa Haugaard Nyhus, Lisbeth Bertelsen, Anders Jakobsen, Torben Schjødt Hansen, Line Nederby
Published 2024-04-01
Article -
12
Heterogeneity of miRNA expression in localized prostate cancer with clinicopathological correlations. by Ahmed Hussein Zedan, Søren Garm Blavnsfeldt, Torben Frøstrup Hansen, Boye Schnack Nielsen, Niels Marcussen, Mindaugas Pleckaitis, Palle Jörn Sloth Osther, Flemming Brandt Sørensen
Published 2017-01-01
Article -
13
Study protocol: fish oil supplement in prevention of oxaliplatin-induced peripheral neuropathy in adjuvant colorectal cancer patients – a randomized controlled trial. (OxaNeuro) by Nina Lykkegaard Gehr, Páll Karlsson, Signe Timm, Signe Christensen, Christian Andreas Hvid, Jana Peric, Torben Frøstrup Hansen, Lotte Lauritzen, Nanna Brix Finnerup, Lise Ventzel
Published 2024-02-01
Article -
14
-
15
Precision medicine applied to metastatic colorectal cancer using tumor-derived organoids and in-vitro sensitivity testing: a phase 2, single-center, open-label, and non-comparative... by Lars Henrik Jensen, Silvia Regina Rogatto, Jan Lindebjerg, Birgitte Havelund, Cecilie Abildgaard, Luisa Matos do Canto, Chris Vagn-Hansen, Claus Dam, Søren Rafaelsen, Torben Frøstrup Hansen
Published 2023-05-01
Article -
16
Pulmonologists-level lung cancer detection based on standard blood test results and smoking status using an explainable machine learning approach by Ricco Noel Hansen Flyckt, Louise Sjodsholm, Margrethe Høstgaard Bang Henriksen, Claus Lohman Brasen, Ali Ebrahimi, Ole Hilberg, Torben Frøstrup Hansen, Uffe Kock Wiil, Lars Henrik Jensen, Abdolrahman Peimankar
Published 2024-12-01
Article